354 related articles for article (PubMed ID: 10331984)
1. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development.
Luetteke NC; Qiu TH; Fenton SE; Troyer KL; Riedel RF; Chang A; Lee DC
Development; 1999 Jun; 126(12):2739-50. PubMed ID: 10331984
[TBL] [Abstract][Full Text] [Related]
2. Null mutation of peroxisome proliferator-activated receptor-interacting protein in mammary glands causes defective mammopoiesis.
Qi C; Kashireddy P; Zhu YT; Rao SM; Zhu YJ
J Biol Chem; 2004 Aug; 279(32):33696-701. PubMed ID: 15161927
[TBL] [Abstract][Full Text] [Related]
3. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y
Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719
[TBL] [Abstract][Full Text] [Related]
5. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha.
Troyer KL; Luetteke NC; Saxon ML; Qiu TH; Xian CJ; Lee DC
Gastroenterology; 2001 Jul; 121(1):68-78. PubMed ID: 11438495
[TBL] [Abstract][Full Text] [Related]
6. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
7. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.
Lee DC; Sunnarborg SW; Hinkle CL; Myers TJ; Stevenson MY; Russell WE; Castner BJ; Gerhart MJ; Paxton RJ; Black RA; Chang A; Jackson LF
Ann N Y Acad Sci; 2003 May; 995():22-38. PubMed ID: 12814936
[TBL] [Abstract][Full Text] [Related]
8. The type 1 (EGFR-related) family of growth factor receptors and their ligands.
Prigent SA; Lemoine NR
Prog Growth Factor Res; 1992; 4(1):1-24. PubMed ID: 1355372
[TBL] [Abstract][Full Text] [Related]
9. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development.
Ciarloni L; Mallepell S; Brisken C
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5455-60. PubMed ID: 17369357
[TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal growth factor-related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis.
Herrington EE; Ram TG; Salomon DS; Johnson GR; Gullick WJ; Kenney N; Hosick HL
J Cell Physiol; 1997 Jan; 170(1):47-56. PubMed ID: 9012784
[TBL] [Abstract][Full Text] [Related]
11. Influence of terminal differentiation and PACAP on the cytokine, chemokine, and growth factor secretion of mammary epithelial cells.
Csanaky K; Doppler W; Tamas A; Kovacs K; Toth G; Reglodi D
J Mol Neurosci; 2014 Jan; 52(1):28-36. PubMed ID: 24323361
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis.
Snedeker SM; Brown CF; DiAugustine RP
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):276-80. PubMed ID: 1986376
[TBL] [Abstract][Full Text] [Related]
13. Amphiregulin: role in mammary gland development and breast cancer.
McBryan J; Howlin J; Napoletano S; Martin F
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):159-69. PubMed ID: 18398673
[TBL] [Abstract][Full Text] [Related]
14. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
[TBL] [Abstract][Full Text] [Related]
15. Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells.
Wagner M; Weber CK; Bressau F; Greten FR; Stagge V; Ebert M; Leach SD; Adler G; Schmid RM
Gastroenterology; 2002 Jun; 122(7):1898-912. PubMed ID: 12055597
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of epidermal growth factor-related proteins in human colorectal tumors.
Ciardiello F; Kim N; Saeki T; Dono R; Persico MG; Plowman GD; Garrigues J; Radke S; Todaro GJ; Salomon DS
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7792-6. PubMed ID: 1715580
[TBL] [Abstract][Full Text] [Related]
17. Identification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors.
Xiao JH; Feng X; Di W; Peng ZH; Li LA; Chambon P; Voorhees JJ
EMBO J; 1999 Mar; 18(6):1539-48. PubMed ID: 10075925
[TBL] [Abstract][Full Text] [Related]
18. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
19. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Sørensen BS; Tørring N; Bor MV; Nexø E
Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094
[TBL] [Abstract][Full Text] [Related]
20. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.
Funatomi H; Itakura J; Ishiwata T; Pastan I; Thompson SA; Johnson GR; Korc M
Int J Cancer; 1997 Jul; 72(3):512-7. PubMed ID: 9247297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
